Stem cell abnormalities in esophagus may lead to Barrett's esophagus
the ONA take:
According to new findings published in the journal Cell Reports, researchers at the University of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania, have found that the esophagus has its own pool of stem cells despite previous findings that suggest the opposite.
The findings of the study could help in better understanding the causes of esophageal cancer and Barrett's esophagus, as well as lead to the development of new treatment options. The researchers knew that cells in the inner layers of the esophagus divide twice weekly to produce cells that ultimately become the specialized cells of the lining of the esophagus. The dying cells slough off into the gastrointestinal tract.
This study determined that there is a subpopulation of stem cells in the deeper layers of the esophagus, disproving the belief that all the cells in the deeper layers are the same.
Stem cells are more likely to rest rather than divide, so it was believed that there were no stem cells in the esophagus due to the regular division of cells. The researchers found that these stem cells divide slowly whereas the other cells in the deeper layers divide regularly. Future studies must be conducted to determine if esophageal stem cell abnormalities lead to Barrett's esophagus.
The esophagus has its own pool of stem cells despite previous findings that suggest the opposite.
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports. The findings could lead to new insights into the development and treatment of esophageal cancer and the precancerous condition known as Barrett's esophagus.
According to the American Cancer Society, more than 18,000 people will be diagnosed with esophageal cancer in the U.S. in 2014 and almost 15,500 people will die from it. In Barrett's esophagus, the lining of the esophagus changes for unknown reasons to resemble that of the intestine, though gastro-esophageal reflux disease or GERD is a risk factor for its development.
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Shifts in Cancer Burden for People With HIV Projected
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|